Bristol Myers Squibb, Hengrui in collaboration licensing
The collaboration licensing deal valuation for Bristol Myers Squibb and Jiangsu Hengrui Pharmaceuticals could reach up to $15.2 billion, spanning oncology,
Most important news & global events daily
The collaboration licensing deal valuation for Bristol Myers Squibb and Jiangsu Hengrui Pharmaceuticals could reach up to $15.2 billion, spanning oncology,
Your cart is currently empty!
Notifications